BIOPHARMACEUTICS AND PHARMACOKINETICS (Theory)


UNIT-I 

Introduction to  Biopharmaceutics

Absorption; Mechanisms of drug absorption through GIT, factors influencing drug
absorption though GIT, absorption of drug from Non per oral extra-vascular
routes, Distribution Tissue permeability of drugs, binding of drugs, apparent, volume
of drug distribution, plasma and tissue protein binding of drugs, factors affecting
protein-drug binding. Kinetics of protein binding, Clinical significance of protein binding of drugs 

UNIT- II 

Elimination: Drug metabolism and basic understanding metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs, renal clearance, Non renal 
routes of drug excretion of drugs

Bioavailability and Bioequivalence: Definition and Objectives of bioavailability, absolute and relative bioavailability, measurement of bioavailability, in-vitro drug
dissolution models, in-vitro-in-vivo correlations, bioequivalence studies, methods to
enhance the dissolution rates and bioavailability of poorly soluble drugs.

UNIT- III 

Pharmacokinetics: Definition and introduction to Pharmacokinetics, Compartment
models, Non compartment models, physiological models, 
One compartment open model
(a). Intravenous Injection (Bolus) 
(b). Intravenous infusion and 
(c) Extra vascular administrations. Pharmacokinetics parameters - KE ,t1/2,Vd,AUC,Ka, Clt and 
CLR- definitions methods of eliminations, understanding of their significance and application

UNIT- IV 

Multicompartment models: Two compartment open model. IV bolus
Kinetics of multiple dosing, steady state drug levels, calculation of loading and mainetnance doses and their significance in clinical settins. 

UNIT- V 

Nonlinear Pharmacokinetics
a. Introduction, 
b. Factors causing Non-linearity. 
c. Michaelis-menton method of estimating parameters, Explanation with example of drugs.
Post a Comment (0)
Previous Post Next Post